Oral Faropenem Sodium and AMR Risk
2026-08-18
The reference article interprets oral faropenem as a penem antibiotic whose convenience and broad β-lactam activity may encourage inappropriate prescribing and contribute to cross-resistance with reserve carbapenems. Its main contribution is a stewardship-focused synthesis linking regulatory status, consumption trends, antimicrobial spectrum, and the need for laboratory-supported use rather than presenting new clinical trial data.
ROS-Responsive LNPs for Mutant RAS mRNA Therapy
2026-08-17
Cai and colleagues developed a combinatorial library of thioketal-containing, ROS-degradable lipids to improve mRNA release selectively in tumor cells. The lead lipid, BAmP-TK-12, delivered DUF5-encoding mRNA, depleted mutant RAS, and produced stronger antitumor activity than a small-molecule RAS inhibitor in the reported models.
TNF-alpha recombinant murine protein for Cell Assays
2026-08-17
Learn how TNF-alpha recombinant murine protein, SKU P1002, can improve the interpretation and reproducibility of murine cell viability, proliferation, and cytotoxicity assays. This scenario-based guide connects cytokine-driven apoptosis with recent evidence on transcription-independent cell death and provides practical handling, optimization, and vendor-selection guidance.
CBD in Orofacial Inflammatory Pain: Mechanisms
2026-08-16
This 2026 study shows that cannabidiol (CBD) can reduce both nociceptive and pain-related affective abnormalities in mouse models of orofacial and chronic inflammatory pain. Its main innovation is the integration of peripheral CB2 signaling, central CB1 pathways, inflammatory and oxidative measurements, and serotonin activity to explain how one intervention influences sensory, emotional, and cognitive pain dimensions.
SM-164 and the Logic of Cell-Death Assays
2026-08-15
SM-164 is a bivalent Smac mimetic that exposes how IAP control, TNFα signaling, and higher-order death assemblies shape tumor-cell fate. This article translates necrosome stoichiometry research into a branch-resolved framework for cancer research and apoptosis assays.
NEDD4L–PRMT5 Control of Colorectal Liver Metastasis
2026-08-14
The reference study identifies NEDD4L as an E3 ubiquitin ligase that restrains colorectal cancer liver metastasis by targeting PRMT5 for degradation. Its in vivo loss-of-function screen and mechanistic validation connect the NEDD4L–PRMT5 axis to AKT1 arginine methylation and AKT/mTOR signaling, providing a framework for studying ubiquitin-dependent control of metastatic colonization.
Moxidectin–Polyene Synergy in Oral Candidiasis
2026-08-14
A 2024 study identifies Moxidectin as a potentiator of amphotericin B and nystatin against Candida albicans, linking synergy to increased fungal ergosterol biosynthesis and polyene binding. The work supports a preclinical strategy for improving polyene activity in oral candidiasis while highlighting the need for pharmacological and safety validation.
Capecitabine for Reliable Viability Assays
2026-08-13
Learn how Capecitabine (SKU A8647) can improve interpretation of viability, proliferation, and cytotoxicity assays across monolayer, organoid, and tumor–stroma models. This scenario-based guide covers prodrug biology, assay design, stock preparation, data interpretation, and practical vendor-selection criteria.
Linoleic Acid (C18:2) Workflow Guide
2026-08-13
Linoleic Acid (C18:2(9Z,12Z), SKU C3108) provides a practical reagent for studying membrane behavior, oxidative stress, erythrocyte injury, epithelial migration, and essential fatty acid deficiency. Because it is water-insoluble and solution stability is limited, it should be prepared in a compatible organic solvent immediately before use rather than applied from long-term aqueous or aged stocks.
From ECM Proteolysis to Memory: An MMP Strategy
2026-08-12
Perineuronal-net degradation connects extracellular-matrix remodeling with social-memory loss in Alzheimer’s disease models. This article positions GM 6001 (Galardin) as a mechanistic research tool for testing that connection while outlining validation, workflow, and translational strategy.
How Kinase Inhibitors Tune p38α Dephosphorylation
2026-08-12
The reference preprint shows that selected kinase inhibitors can do more than occupy the p38α catalytic site: they can reshape the activation loop to accelerate WIP1-mediated dephosphorylation. This dual-action concept links inhibitor binding, kinase conformation, and phosphatase substrate recognition, suggesting a strategy for improving pathway inhibition while highlighting the need for cellular and in vivo validation.
Calpeptin and EV Release in Triple-Negative Breast Cancer
2026-08-11
McNamee et al. systematically tested calpeptin and three other pathway-directed compounds as inhibitors of extracellular vesicle release from triple-negative breast cancer cells. Their central finding was that broad suppression of heterogeneous EV populations, rather than selective removal of one presumed vesicle class, may be required to substantially reduce the transfer of aggressive phenotypic traits.
Linoleic Acid (C18:2) in Redox Research
2026-08-11
Linoleic Acid (C18:2(9Z,12Z)) is an essential omega-6 fatty acid used to study membrane biology, oxidative stress, and lipid metabolism. Product C3108 is an oil-based research reagent whose handling requirements make solvent choice, fresh preparation, and assay-specific controls central to reproducibility.
P2RX1–CaMKII Drives Mitochondrial Apoptosis in Ph+ ALL
2026-08-09
Li et al. identify P2RX1 as a mechanistic link between calcium dysregulation, CaMKII activation, PI3K/Akt suppression, and mitochondrial apoptosis in Philadelphia chromosome-positive acute lymphoblastic leukemia. The findings suggest that P2RX1 expression may indicate poor disease biology while also revealing a treatment-sensitive mitochondrial vulnerability that can be evaluated with complementary cell-death assays.
CHIR 99021 Trihydrochloride in Organoid Design
2026-08-08
CHIR 99021 trihydrochloride is a selective GSK-3 inhibitor for probing stemness, lineage choice, and organoid scalability. This article connects its molecular activity with a tunable human intestinal organoid framework and translates that logic into better assay design for metabolism and disease research.
571 records 9/39 page Previous Next First page 上5页 678910 下5页 Last page